Literature DB >> 19724883

Notch1 induces enhanced expression of Delta-like-1 in the U251MG glioma cell line.

Chun-Fa Qian1, Wei Yan, Jun-Xia Zhang, Lei Shi, Jin Qian, Zhen Fu, Chun-Sheng Kang, Ning Liu, Yong-Ping You.   

Abstract

The Notch signaling pathway takes part in coordinated regulation of cell growth, survival and differentiation. Previous findings have shown that Notch1 and Delta-like-1 (DLL1) are overexpressed in many glioma cell lines and primary human gliomas. Down-regulation of DLL1 by RNA interference inhibits proliferation and induces apoptosis in multiple glioma cell lines. Our studies showed that Notch1 expression plasmid induced more expression of DLL1 in the U251MG glioma cell line. Adversely, blocking Notch1 receptors down-regulated the expression of DLL1. Both down-regulating DLL1 and blocking Notch1 receptors induced U251MG cell apoptosis and proliferation inhibition, and combining the two treatments produced stronger effects than the sum of a single treatment. These findings suggest a positive feedback loop between Notch1 and DLL1, which may become an effective combined therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19724883     DOI: 10.3892/ijmm_00000251

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.

Authors:  Xiaolin Huang; Li Wang; He Zhang; Haibo Wang; Xiaoping Zhao; Guanxiang Qian; Jifan Hu; Shengfang Ge; Xianqun Fan
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

2.  Notch signaling regulates remodeling and vessel diameter in the extraembryonic yolk sac.

Authors:  Jessica N Copeland; Yi Feng; Naveen K Neradugomma; Patrick E Fields; Jay L Vivian
Journal:  BMC Dev Biol       Date:  2011-02-25       Impact factor: 1.978

3.  MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.

Authors:  Pasqualino de Antonellis; Chiara Medaglia; Emilio Cusanelli; Immacolata Andolfo; Lucia Liguori; Gennaro De Vita; Marianeve Carotenuto; Annamaria Bello; Fabio Formiggini; Aldo Galeone; Giuseppe De Rosa; Antonella Virgilio; Immacolata Scognamiglio; Manuela Sciro; Giuseppe Basso; Johannes H Schulte; Giuseppe Cinalli; Achille Iolascon; Massimo Zollo
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

4.  Jagged-1 Signaling in the Bone Marrow Microenvironment Promotes Endothelial Progenitor Cell Expansion and Commitment of CD133+ Human Cord Blood Cells for Postnatal Vasculogenesis.

Authors:  Mika Ishige-Wada; Sang-Mo Kwon; Masamichi Eguchi; Katsuto Hozumi; Hideki Iwaguro; Taro Matsumoto; Noboru Fukuda; Hideo Mugishima; Haruchika Masuda; Takayuki Asahara
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

Review 5.  The Role of DLLs in Cancer: A Novel Therapeutic Target.

Authors:  Meng-Xi Xiu; Yuan-Meng Liu; Bo-Hai Kuang
Journal:  Onco Targets Ther       Date:  2020-05-07       Impact factor: 4.147

6.  Expression of DLK1 Gene in the Bone Marrow Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance.

Authors:  Lan-Zhu Yue; Rong Fu; Hua-Quan Wang; Li-Juan Li; Er-Bao Ruan; Guo-Jin Wang; Wen Qu; Yong Liang; Jing Guan; Yu-Hong Wu; Hong Liu; Jia Song; Xiao-Ming Wang; Li-Min Xing; Zong-Hong Shao
Journal:  Cancer Biol Med       Date:  2012-09       Impact factor: 4.248

Review 7.  Developmental Perspectives on Arterial Fate Specification.

Authors:  Dongying Chen; Martin A Schwartz; Michael Simons
Journal:  Front Cell Dev Biol       Date:  2021-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.